Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.33 |
| ▸ | ADAM10 | O14672 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP14 | P50281 | 1/20 | 0.33 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.33 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24714559 | 1.00 | HTR7 (0.41) | HTR7CASP3ARMEN1GABRA1 | |
| SCHEMBL17952377 | 0.91 | AR (0.37) | HTR7CASP3ARMEN1GABRA1 | |
| SCHEMBL17952499 | 0.86 | HTR7 (0.39) | HTR7CASP3ARMEN1ADAM10 | |
| SCHEMBL17952253 | 0.85 | GABRA1 (0.37) | HTR7GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL17173455 | 0.84 | HTR7 (0.40) | HTR7CASP3ARMEN1EGLN2 | |
| SCHEMBL17952380 | 0.84 | CASP3 (0.37) | HTR7CASP3ARADAM10MMP2 | |
| SCHEMBL17169539 | 0.83 | HTR7 (0.40) | HTR7CASP3ARMEN1GABRA1 | |
| SCHEMBL17952598 | 0.83 | CASP3 (0.35) | HTR7CASP3AREGLN2ALDH1A1 | |
| SCHEMBL17169534 | 0.82 | HTR7 (0.39) | HTR7CASP3ARMEN1GABRA1 | |
| SCHEMBL17169531 | 0.81 | TSHR (0.37) | ARMEN1ALDH1A1KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9911928-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-03-06 | — | — | US | disclosed |
| US-9911928-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-03-06 | — | — | US | disclosed |
| US-9905785-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-02-27 | — | — | US | disclosed |
| US-9905785-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-02-27 | — | — | US | disclosed |
| US-20160276603-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2016-09-22 | — | — | US | disclosed |
| US-20150295189-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2015-10-15 | — | — | US | disclosed |
| US-20150295189-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2015-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160276603-A1 | Organic Electroluminescent Materials and Devices | EML4, BICRA, TBCB | HTR7 1804/4885CASP3 2726/4885AR 2937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.